Expression of OXA-type and SFO-1 β-lactamases induces changes in peptidoglycan composition and affects bacterial fitness

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 4, 2012, Pages 1877-1884

  Fernández, Ana ^a   Pérez, Astrid ^a   Ayala, Juan A ^b   Mallo, Susana ^a   Rumbo Feal, Soraya ^a   Tomás, Maria ^a   Poza, Margarita ^a   Bou, Germán ^a  

^a HOSPITAL JUAN CANALEJO   (Spain)

^b CSIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AZTREONAM; BETA LACTAMASE; BETA LACTAMASE SFO 1; CARBAPENEM; CEFTAZIDIME; CEPHALOSPORIN; CLOXACILLIN; OXACILLIN; PENICILLIN G; PEPTIDOGLYCAN; UNCLASSIFIED DRUG;

ACINETOBACTER BAUMANNII; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL FITNESS; BACTERIAL PHENOMENA AND FUNCTIONS; BIOFILM; CARBOHYDRATE ANALYSIS; CONTROLLED STUDY; ESCHERICHIA COLI; FEMALE; IN VITRO STUDY; IN VIVO STUDY; KLEBSIELLA PNEUMONIAE; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSEUDOMONAS AERUGINOSA;

ANIMALS; BETA-LACTAMASES; BIOFILMS; CLONING, MOLECULAR; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; MICE; MICROSCOPY, ELECTRON, TRANSMISSION; PEPTIDOGLYCAN; PHENOTYPE; PLASMIDS;

EID: 84858649197     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.05402-11     Document Type: Article

References (46)

1. Ambler RP. 1980. The structure of beta-lactamases. Philos. Trans. R. Soc. Lond. B Biol. Sci. 289:321-331.
2. Andersson DI, Levin BR. 1999. The biological cost of antibiotic resistance. Curr. Opin. Microbiol. 2:489-493. (Pubitemid 29477174)
3. Aranda J, et al. 2010. The cation-uptake regulators AdcR and Fur are necessary for full virulence of Streptococcus suis. Vet. Microbiol. 144:246-249.
4. Barnaud G, et al. 1998. Salmonella enteritidis: AmpC plasmid-mediated inducible beta-lactamase (DHA-1) with an ampR gene from Morganella morganii. Antimicrob. Agents Chemother. 42:2352-2358. (Pubitemid 28420377)
5. Bjorkman J, Andersson DI. 2000. The cost of antibiotic resistance from a bacterial perspective. Drug Resist. Updat. 3:237-245.
6. Bonnet R, et al. 2000. A novel CTX-M beta-lactamase (CTX-M-8) in cefotaxime-resistant Enterobacteriaceae isolated in Brazil. Antimicrob. Agents Chemother. 44:1936-1942. (Pubitemid 30422952)
7. Bou G, et al. 2002. Identification and broad dissemination of the CTXM-14 beta-lactamase in different Escherichia coli strains in the northwest area of Spain. J. Clin. Microbiol. 40:4030-4036. (Pubitemid 35285785)
8. Bou G, Martinez-Beltran J, Cervero G, Perez-Diaz JC. 1999. Biochemical and genetic characteristics of TEM-29B, a novel extended spectrum beta-lactamase. FEMS Microbiol. Lett. 174:185-190. (Pubitemid 29179451)
9. Bou G, Oliver A, Martinez-Beltran J. 2000. OXA-24, a novel class D beta-lactamase with carbapenemase activity in an Acinetobacter baumannii clinical strain. Antimicrob. Agents Chemother. 44:1556-1561. (Pubitemid 30340794)
10. Bou G, Oliver A, Ojeda M, Monzon C, Martinez-Beltran J. 2000. Molecular characterization of FOX-4, a new AmpC-type plasmid-mediated beta-lactamase from an Escherichia coli strain isolated in Spain. Antimicrob. Agents Chemother. 44:2549-2553. (Pubitemid 30650915)
11. Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
12. Bradford PA. 2001. Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin. Microbiol. Rev. 14:933-951. (Pubitemid 32979636)
13. Bush K, Jacoby GA. 2010. Updated functional classification of betalactamases. Antimicrob. Agents Chemother. 54:969-976.
14. Cariss SJ, et al. 2010. YieJ (CbrC) mediates CreBC-dependent colicin E2 tolerance in Escherichia coli. J. Bacteriol. 192:3329-3336.
15. Fernandez A, et al. 2007. Interspecies spread of CTX-M-32 extendedspectrum beta-lactamase and the role of the insertion sequence IS1 in down-regulating bla CTX-M gene expression. J. Antimicrob. Chemother. 59:841-847. (Pubitemid 47073353)
16. Fernandez A, et al. 2011. Emergence in Spain of a multidrug-resistant Enterobacter cloacae clinical isolate producing SFO-1 extended-spectrum beta-lactamase. J. Clin. Microbiol. 49:822-828.
17. Fortineau N, Poirel L, Nordmann P. 2001. Plasmid-mediated and inducible cephalosporinase DHA-2 from Klebsiella pneumoniae. J. Antimicrob. Chemother. 47:207-210. (Pubitemid 32149530)
18. Gallant CV, et al. 2005. Common beta-lactamases inhibit bacterial biofilm formation. Mol. Microbiol. 58:1012-1024. (Pubitemid 41667222)
19. Glauner B. 1988. Separation and quantification of muropeptides with high-performance liquid chromatography. Anal. Biochem. 172:451-464.
20. Jacoby GA. 2009. AmpC beta-lactamases. Clin. Microbiol. Rev. 22:161-182.
21. Kong KF, et al. 2005. Pseudomonas aeruginosa AmpR is a global transcriptional factor that regulates expression ofAmpCand PoxB beta-lactamases, proteases, quorum sensing, and other virulence factors. Antimicrob. Agents Chemother. 49:4567-4575.
22. Levin BR. 2001. Minimizing potential resistance: a population dynamics view. Clin. Infect. Dis. 33(Suppl. 3):S161-S169. (Pubitemid 32835786)
23. Livermore DM. 1987. Radiolabelling of penicillin-binding proteins (PBPs) in intact Pseudomonas aeruginosa cells: consequences of betalactamase activity by PBP-5. J. Antimicrob. Chemother. 19:733-742. (Pubitemid 17092058)
24. Livermore DM, et al. 2007. CTX-M: changing the face of ESBLs in Europe. J. Antimicrob. Chemother. 59:165-174. (Pubitemid 47072053)
25. Luo N, et al. 2005. Enhanced in vivo fitness of fluoroquinolone-resistant Campylobacter jejuni in the absence of antibiotic selection pressure. Proc. Natl. Acad. Sci. U. S. A. 102:541-546. (Pubitemid 40282701)
26. Mallo S, et al. 2010. A tripeptide deletion in the R2 loop of the class C beta-lactamase enzyme FOX-4 impairs cefoxitin hydrolysis and slightly increases susceptibility to beta-lactamase inhibitors. J. Antimicrob. Chemother. 65:1187-1194.
27. Massova I, Mobashery S. 1998. Kinship and diversification of bacterial penicillin-binding proteins and beta-lactamases. Antimicrob. Agents Chemother. 42:1-17. (Pubitemid 28053319)
28. Matsumoto Y, Inoue M. 1999. Characterization of SFO-1, a plasmid-mediated inducible class A beta-lactamase from Enterobacter cloacae. Antimicrob. Agents Chemother. 43:307-313. (Pubitemid 29079164)
29. Merino M, et al. 2010. OXA-24 carbapenemase gene flanked by XerC/XerD-like recombination sites in different plasmids from different Acinetobacter species isolated during a nosocomial outbreak. Antimicrob. Agents Chemother. 54:2724-2727.
30. Merino M, et al. 2010. Role of changes in the L3 loop of the active site in the evolution of enzymatic activity of VIM-type metallo-beta-lactamases. J. Antimicrob. Chemother. 65:1950-1954.
31. Morosini MI, Ayala JA, Baquero F, Martinez JL, Blazquez J. 2000. Biological cost of AmpC production for Salmonella enterica serotype Typhimurium. Antimicrob. Agents Chemother. 44:3137-3143.
32. Moya B, et al. 2009. Beta-lactam resistance response triggered by inactivation of a nonessential penicillin-binding protein. PLoS Pathog. 5:e1000353.
33. Moya B, Juan C, Alberti S, Perez JL, Oliver A. 2008. Benefit of having multiple ampD genes for acquiring beta-lactam resistance without losing fitness and virulence in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 52:3694-3700.
34. Mroczkowska JE, Barlow M. 2008. Fitness trade-offs in blaTEM evolution. Antimicrob. Agents Chemother. 52:2340-2345.
35. Naas T, Oxacelay C, Nordmann P. 2007. Identification of CTX-M-type extended-spectrum-beta-lactamase genes using real-time PCR and pyrosequencing. Antimicrob. Agents Chemother. 51:223-230. (Pubitemid 46047710)
36. Nakano R, et al. 2004. CFE-1, a novel plasmid-encoded AmpC betalactamase with an ampR gene originating from Citrobacter freundii. Antimicrob. Agents Chemother. 48:1151-1158. (Pubitemid 38405468)
37. Poirel L, Naas T, Nordmann P. 2010. Diversity, epidemiology, and genetics of class D beta-lactamases. Antimicrob. Agents Chemother. 54:24-38.
38. Porto A, Ayala J, Gutkind G, Di Conza J. 2010. A novel OXA-10-like beta-lactamase is present in different Enterobacteriaceae. Diagn. Microbiol. Infect. Dis. 66:228-229.
39. Pratt LA, Kolter R. 1998. Genetic analysis of Escherichia coli biofilm formation: roles of flagella, motility, chemotaxis and type I pili. Mol. Microbiol. 30:285-293. (Pubitemid 28480180)
40. Reisbig MD, Hanson ND. 2002. The ACT-1 plasmid-encoded AmpC beta-lactamase is inducible: detection in a complex beta-lactamase background. J. Antimicrob. Chemother. 49:557-560. (Pubitemid 34223681)
41. Sauvage E, Kerff F, Terrak M, Ayala JA, Charlier P. 2008. The penicillinbinding proteins: structure and role in peptidoglycan biosynthesis. FEMS Microbiol. Rev. 32:234-258. (Pubitemid 351257821)
42. Suwalak S, Voravuthikunchai SP. 2009. Morphological and ultrastructural changes in the cell structure of enterohaemorrhagic Escherichia coli O157:H7 following treatment with Quercus infectoria nut galls. J. Electron Microsc. (Tokyo) 58:315-320.
43. Tayler AE, et al. 2010. Induction of beta-lactamase production in Aeromonas hydrophila is responsive to beta-lactam-mediated changes in peptidoglycan composition. Microbiology 156:2327-2335.
44. Vollmer W, Blanot D, de Pedro MA. 2008. Peptidoglycan structure and architecture. FEMS Microbiol. Rev. 32:149-167. (Pubitemid 351257814)
45. Walsh TR, Toleman MA, Poirel L, Nordmann P. 2005. Metallo-beta- lactamases: the quiet before the storm? Clin. Microbiol. Rev. 18:306-325.
46. Walther-Rasmussen J, Hoiby N. 2006. OXA-type carbapenemases. J. Antimicrob. Chemother. 57:373-383. (Pubitemid 43240190)